There were no or small differences with the exception of the 3R/4R ratio in the TBS soluble fraction for CBD, which was clearly lower in Cohort 1 compared with controls and AD, while for Cohort 2 there was no difference. The gene discussed is OPN1MW; the disease is Alzheimer disease.